Treatment of Skin Disease

Comprehensive Therapeutic Strategies

6th Edition - September 17, 2021
Authors: Mark Lebwohl, Ian H. Coulson, Dedee Murrell
Editor: Warren R. Heymann
Language: English
Hardback ISBN:
9 7 8 - 0 - 7 0 2 0 - 8 2 1 0 - 8
eBook ISBN:
9 7 8 - 0 - 7 0 2 0 - 8 2 1 1 - 5

Covering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and D… Read more

Purchase options

Info / Buy

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Request a sales quote

Covering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and Dedee Murrell, is your go-to resource for authoritative, evidence-based treatment strategies in your daily practice. This award-winning text provides guidance on the fast-moving dermatological therapy options for virtually any skin disease you’re likely to encounter, including third-line and unusual therapies when initial options have not been successful. Summaries of each treatment strategy are accompanied by detailed discussions of treatment choices, with ratings on a consistent scale ranging from clinical studies to anecdotal reports.

Cover image
Title page
Table of Contents
Copyright
Preface
List of Contributors
Acknowledgments
Dedication
Evidence Levels
Credits
Treatment of Skin Disease Previous Edition Contributors
1. Acanthosis nigricans
Management Strategy
2. Acne keloidalis nuchae
Management Strategy
3. Acne vulgaris
Management Strategy
4. Acrodermatitis enteropathica
Management Strategy
5. Actinic keratosis
Management Strategy
6. Actinic prurigo: (Synonyms: hereditary polymorphic light eruption of American Indians, Hutchinson summer prurigo, photodermatitis in North American Indians)
Management Strategy
7. Actinomycosis
Management Strategy
Specific Investigations
8. Acute generalized exanthematous pustulosis
Management Strategy
9. Allergic contact dermatitis and photoallergy
Management Strategy
10. Alopecia areata
Management Strategy
11. Amyloidosis
Management Strategy
12. Androgenetic alopecia
Management Strategy
13. Angiolymphoid hyperplasia with eosinophilia
Management Strategy
14. Angular cheilitis
Management Strategy
15. Antiphospholipid syndrome
Management Strategy
16. Aphthous stomatitis
Management Strategy
17. Atopic dermatitis
Management Strategy
18. Atypical fibroxanthoma
Management Strategy
19. Atypical nevi
Management Strategy
20. Autoimmune progesterone dermatitis
Management Strategy
21. Bacillary angiomatosis
Management Strategy
22. Balanitis
Management Strategy
23. Basal cell carcinoma
Management Strategy
24. Becker nevus
Management Strategy
25. Bed bugs
Management Strategy
26. Behçet disease
Management Strategy
27. Bites and stings
Management Strategy
28. Blastomycosis
Management Strategy
Guidelines
29. Blistering distal dactylitis
Management Strategy
30. Body dysmorphic disorder (dermatologic non-disease): Synonyms: Dermatologic non-disease, Body dysmorphic disease, Dysmorphophobia
Management Strategy
31. Bowen disease and erythroplasia of Queyrat
Introduction
Diagnosis
Management Strategy
32. Bullous pemphigoid
Management Strategy
Therapies
33. Burning mouth syndrome (glossodynia)
Management Strategy
34. Calcinosis cutis
Management Strategy
35. Calciphylaxis
Management Strategy
36. Capillaritis (pigmented purpuric dermatoses, purpura pigmentosa)
Management Strategy
37. Cat scratch disease
Management Strategy
38. Cellulite
Management Strategy
39. Cellulitis and erysipelas
Management Strategy
40. Chancroid
Diagnosis and Management Strategy
41. Chilblains
Management Strategy
42. Chondrodermatitis nodularis helicis chronicus
Management Strategy
43. Chromoblastomycosis
Management Strategy
44. Chronic actinic dermatitis
Management Strategy
45. Coccidioidomycosis
Management Strategy
46. Condyloma acuminata
Management Strategy
47. COVID-19 dermatoses
COVID-19 Related Rashes In Adults
Pediatric Multisystem Inflammatory Syndrome
48. Cryopyrin-associated periodic syndrome (CAPS)
Management Strategy
49. Cryptococcosis
Management Strategy
50. Cutaneous candidiasis and chronic mucocutaneous candidiasis
Cutaneous Candidiasis
Management Strategy
Chronic Mucocutaneous Candidiasis
Management Strategy
51. Cutaneous larva migrans
Management Strategy
52. Cutaneous polyarteritis nodosa
Management Strategy
53. Darier disease
Management Strategy
54. Decubitus (pressure) ulcers
Management Strategy
55. Delusions of parasitosis
Management Strategy
56. Dermatitis artefacta
Management Strategy
57. Dermatitis herpetiformis
Management Strategy
58. Dermatofibrosarcoma protuberans
Management Strategy
59. Dermatomyositis
Management Strategy
60. Diaper dermatitis
Management Strategy
61. Discoid (nummular) eczema
Management Strategy
62. Discoid lupus erythematosus
Management Strategy
63. Dissecting cellulitis of the scalp
Management Strategy
64. Dress syndrome: drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DiHS)
Management Strategy
65. Drug eruptions
Management Strategy
66. Eosinophilic fasciitis
Management Strategy
67. Epidermal nevi
Management Strategy
68. Epidermodysplasia verruciformis
Management Strategy
69. Epidermolysis bullosa
Management Strategy
70. Epidermolysis bullosa acquisita
Management Strategy
71. Erosive pustular dermatosis
Management Strategy
72. Erythema annulare centrifugum
Background
Diagnosis/Management Strategy
73. Erythema dyschromicum perstans
Management Strategy
74. Erythema elevatum diutinum
Management Strategy
75. Erythema multiforme
Management Strategy
76. Erythema nodosum
Management Strategies
77. Erythrasma
Management Strategy
78. Erythroderma
Management Strategy
79. Erythrokeratodermas
Management Strategy
80. Erythromelalgia
Management Strategy
81. Erythropoietic protoporphyria
Management Strategy
82. Extramammary Paget disease
Management Strategy
83. Fabry disease
Management Strategy
84. Flushing
Management Strategy
85. Follicular mucinosis
Management Strategy
86. Folliculitis
Management Strategy
87. Folliculitis decalvans
Management Strategy
88. Fox–Fordyce disease
Management Strategy
89. Furunculosis
Management Strategy
90. Geographic tongue
Management Strategy
91. Gianotti–Crosti syndrome
Management Strategy
92. Gonorrhea
Management Strategy
Special Considerations
93. Graft-versus-host disease
Management Strategy
Acute Gvhd
Chronic Gvhd
94. Granuloma annulare
Management Strategy
Localized Granuloma Annulare
Generalized (Disseminated) Granuloma Annulare
95. Granuloma faciale
Management Strategy
96. Granuloma inguinale
Management Strategy
Special Considerations
97. Granulomatous cheilitis
Management Strategy
98. Hailey–Hailey disease
Management Strategy
99. Hand and foot eczema (endogenous, dyshidrotic eczema, pompholyx)
Management Strategy
100. Hemangiomas
Management Strategy
101. Hereditary angioedema
Management Strategy
Acute Angioedema
Long-Term Prophylaxis
Short-Term Prophylaxis (STP) for Prevention of Relapse Due to Dental and Surgical Interventions
Acute Angioedema
Long-Term Prophylaxis
Short-Term Prophylaxis
Treatment in Children
Hereditary Angioedema with Normal C1-INH
102. Hereditary hemorrhagic telangiectasia
Management Strategy
103. Herpes genitalis
Management Strategy
Novel and Other Therapies
Prevention
104. Herpes labialis
Management Strategy
Other Therapies
105. Herpes zoster
Management Strategy
106. Hidradenitis suppurativa
Management Strategy
107. Histoplasmosis
Management Strategy
108. Hydroa vacciniforme
Management Strategy
109. Hyperhidrosis
Management Strategy
110. Hypertrichosis and hirsutism
Introduction
Management Strategy
111. Hypopigmented disorders
Management Strategy
112. Ichthyoses
Management Strategy
113. Impetigo
Management Strategy
114. Inducible urticarias, aquagenic pruritus, and cholinergic pruritus
Inducible Urticarias
Symptomatic Dermographism
Cholinergic Urticaria
Cold Urticaria
Heat Urticaria
Delayed Pressure Urticaria
Solar Urticaria
Aquagenic Pruritus
Cholinergic Pruritus
115. Irritant contact dermatitis
Management Strategy
116. Jellyfish stings
Clinical and Demographic Features
Cutaneous Manifestations of Jellyfish Stings
Management Strategy
117. Jessner lymphocytic infiltrate
Management Strategy
118. Juvenile plantar dermatosis
Management Strategy
119. Juvenile xanthogranuloma
Management Strategy
120. Kaposi sarcoma
Management Strategy
121. Kawasaki disease
Management Strategies
Kawasaki Disease: an Overview
Kawasaki Disease: an Update on Treatment
122. Keloids
Management Strategy
123. Keratoacanthoma
Management Strategy
124. Keratosis lichenoides chronica
Introduction
Management Strategy
125. Keratosis pilaris and variants
Management Strategy
126. Langerhans cell histiocytosis
Management Strategy
127. Leg ulcers
Management Strategy
128. Leiomyoma
Management Strategy
129. Leishmaniasis
Management Strategy
130. Lentigo maligna
Management Strategy
131. Leprosy (including reactions)
Management Strategy
132. Leukocytoclastic vasculitis (cutaneous small vessel vasculitis)
Management Strategy
133. Lichen myxedematosus
Management Strategy
134. Lichen nitidus
Management Strategy
135. Lichen planopilaris
Management Strategy
136. Lichen planus
Management Strategy
137. Lichen sclerosus
Management Strategy
138. Lichen simplex chronicus
Management Strategy
139. Linear IgA bullous dermatosis
Management Strategy
140. Lipodermatosclerosis
Management Strategy
141. Livedo reticularis
Management Strategy
142. Livedoid vasculopathy
Management Strategy
143. Lyme borreliosis
Management Strategy
Specific Investigations
144. Lymphangioma circumscriptum
Management Strategies
145. Lymphedema
Management Strategies
146. Lymphocytoma cutis
Management Strategy
147. Lymphogranuloma venereum
Management Strategy
148. Lymphomatoid papulosis
Management Strategy
149. Malignant atrophic papulosis
Management Strategy
150. Malignant melanoma
Management Strategy
151. Mastocytoses
Management Strategy
152. Melasma
Management Strategy
153. Merkel cell carcinoma
Introduction
Management Strategy
154. Methicillin-resistant Staphylococcus aureus (MRSA)
Management Strategy
Specific Investigations
155. Miliaria
Management Strategy
156. Molluscum contagiosum
Management Strategy
157. Morphea
Management Strategy
158. Mucoceles
Management Strategy
159. Mucous membrane pemphigoid
Management Strategy
160. Mycetoma: Eumycetoma and actinomycetoma
Management Strategy
161. Mycobacterial (atypical) skin infections
Mycobacterium Marinum
Rapidly Growing Mycobacteria
Mycobacterium Ulcerans
162. Mycosis fungoides and Sézary syndrome
Management Strategy
163. Myiasis
Management Strategy
164. Myxoid cyst
Management Strategy
165. Nail psoriasis
Management Strategy
166. Necrobiosis lipoidica
Management Strategy
167. Necrolytic acral erythema
Management Strategy
168. Necrolytic migratory erythema
Management Strategy
169. Neurofibromatosis, type 1
Management Strategy
170. Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
Management Strategy
171. Nevus sebaceus
Management Strategy
172. Notalgia paresthetica
Management Strategy
173. Onchocerciasis
Management Strategy
174. Oral lichen planus
Management Strategy
175. Orf
Management Strategy
176. Palmoplantar keratoderma
Management Strategy
177. Palmoplantar pustulosis
Management Strategy
178. Panniculitis
Management Strategy
Lupus Panniculitis
Nodular Vasculitis
Pancreatic Panniculitis
Cytophagic Histiocytic Panniculitis
α1-Antitrypsin Deficiency Panniculitis
179. Papular urticaria
Management Strategy
180. Paracoccidioidomycosis
Management Strategy
181. Parapsoriasis
Management Strategy
Small Plaque Parapsoriasis
Large Plaque Parapsoriasis
182. Paronychia
Management Strategy
183. Parvovirus infection
Management Strategy
184. Pediculosis
Pediculosis Capitis
Pediculosis Corporis
Pediculosis Pubis
Phthiriasis Palpebrarum
185. Pemphigus
Management Strategy
186. Perforating dermatoses
Management Strategy
187. Perioral dermatitis
Management Strategy
188. Peutz–Jeghers syndrome
Management Strategy
189. Pinta and yaws
190. Pitted and ringed keratolysis (keratolysis plantare sulcatum)
Management Strategy
191. Pityriasis lichenoides chronica
Management Strategy
192. Pityriasis lichenoides et varioliformis acuta
Management Strategy
193. Pityriasis rosea
Management Strategy
194. Pityriasis rubra pilaris
Management Strategy
Systematic Reviews
195. Polycystic ovary syndrome
Management Strategy
196. Polymorphic light eruption
Management Strategy
197. Porokeratoses
Management Strategy
198. Porphyria cutanea tarda
Management Strategy
199. Port wine stain (‘nevus flammeus’)
Management Strategy
200. Postinflammatory hyperpigmentation and other disorders of hyperpigmentation
Introduction
Postinflammatory Hyperpigmentation
Other Disorders of Hyperpigmentation
Management Strategy
201. Pregnancy dermatoses
Polymorphic Eruption of Pregnancy
Pemphigoid Gestationis
Intrahepatic Cholestasis Of Pregnancy
Atopic Eruption Of Pregnancy
202. Pretibial myxedema
Management Strategy
203. Prurigo nodularis
Management Strategy
204. Prurigo pigmentosa
Management Strategy
205. Pruritus
Introduction
Management Strategy
Chronic Pruritus of Unknown Origin (CPUO)
Itch in Dermatologic Diseases
Systemic Causes of Chronic Itch
Treatment of Itch in Special Populations
206. Pruritus ani
Management Strategy
207. Pruritus vulvae
Management Strategy
Situational Treatment Considerations
Select Publications on Etiology and Management
208. Pseudofolliculitis barbae
Introduction
Management Strategy
209. Pseudoxanthoma elasticum
Management Strategy
210. Psoriasis
Management Strategy
Guttate Psoriasis
Inverse Psoriasis
Erythrodermic Psoriasis
Generalized Pustular Psoriasis
211. Psychogenic excoriation
Management Strategy
212. Pyoderma gangrenosum
Management Strategy
213. Pyogenic granuloma
Management Strategy
214. Radiation dermatitis
Management Strategy
215. Raynaud disease and phenomenon
Management Strategy
216. Reactive arthritis
Management Strategy
217. Relapsing polychondritis
Management Strategy
218. Rhinophyma
Management Strategy
219. Rocky Mountain spotted fever and other rickettsial infections
Rickettsial Spotted Fevers
Typhus Group
Rickettsialpox
Q Fever
Ehrlichiosis
220. Rosacea
Management Strategy
Papulopustular Rosacea
Persistent Facial Erythema (Erythematotelangiectatic Rosacea)
Flushing of Rosacea
Rosacea Lymphedema (Morbihan Disease)
Ocular Rosacea
Rosacea Fulminans/Pyoderma Faciale
221. Sarcoidosis
Management Strategy
222. Scabies
Management Strategy
General Management Considerations
223. Scleredema
Management Strategy
224. Scleroderma (systemic sclerosis)
Management Strategy
225. Sebaceous gland hyperplasia
Management Strategy
226. Seborrheic eczema
Management Strategy
Non-Scalp Disease
Scalp Disease
227. Seborrheic keratosis
Management Strategy
228. Sporotrichosis
Management Strategy
229. Squamous cell carcinoma
Management Strategy
230. Staphylococcal scalded skin syndrome
Management Strategy
231. Steatocystoma multiplex
Management Strategy
232. Stoma care
Management Strategy
233. Striae
Management Strategy
234. Subacute cutaneous lupus erythematosus
Management Strategy
235. Subcorneal pustular dermatosis
Management Strategy
236. Subcutaneous fat necrosis of the newborn
Management Strategy
Surgical Management
237. Sweet syndrome
Management Strategy
238. Syphilis
Management Strategy
Diagnostics and Treatment
239. Syringomata
Management Strategy
240. Tinea capitis
Management Strategy
241. Tinea corporis and tinea cruris
Management Strategy
242. Tinea pedis
Management Strategy
243. Tinea unguium
Management Strategy
244. Tinea versicolor (pityriasis versicolor)
Management Strategy
245. Toxic epidermal necrolysis and Stevens–Johnson syndrome
Management Strategy
246. Transient acantholytic dermatosis (Grover disease)
Management Strategy
247. Trichotillomania
Diagnosis
Management Strategy
248. Tuberculosis (cutaneous) and tuberculids
Clinical Features
Management Strategy
Treatment
249. Urticaria and angioedema
Urticaria
Management Strategy
Non-Mast Cell–Mediated Angioedema
Management Strategy for Bradykinin-Mediated Angioedema
250. Varicella
Management Strategy
251. Viral exanthems: Rubella, roseola, rubeola and enteroviruses
Rubella
Management Strategy
Roseola
Management Strategy
Rubeola
Management Strategy
Enteroviruses
Management Strategy
252. Vitiligo
Management Strategy
Emerging Treatments
253. Vulvodynia
Introduction
Management Strategy
Specific Investigations
254. Warts
Management Strategy
255. Wells syndrome
Management Strategy
256. Xanthomas
Management Strategy
257. Xeroderma pigmentosum
Management Strategy
258. Xerosis
Management Strategy
259. Yellow nail syndrome
Management Strategy
Index

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Treatment of Skin Disease

Comprehensive Therapeutic Strategies

Purchase options

Save 50% on book bundles

Institutional subscription on ScienceDirect

Warren R. Heymann

Mark Lebwohl

Ian H. Coulson

Dedee Murrell